title: Molecular analyses of HIV-1 group O and HIV-2 variants from Africa.
abstract: Genetic variation among HIV isolates creates challenges for their detection by serologic and genetic techniques. To characterize the sequence variation and its correlation to serologic diversity of HIV-1 Group O and HIV-2 isolates, samples were identified by differential reactivity in selected commercial and research assays. Analysis of sera from Equatorial Guinea (EG) led to identification of 4 HIV-1 Group O variants. Viral RNA, extracted from these samples was used to PCR amplify overlapping sequences of the entire envelope gene using multiple primer pairs. Sequence analysis indicated that the V3 loop nucleotide and protein sequences aligned more closely with HIVANT70 compared to other Group O sequences. The amino acid sequences at the octameric tip of the V3 loop were RIGPLAWY, RIGPMAWY, or GLGPLAVY. The tetrameric tip GPLA is represented only once in the published 1994 HIV database (Los Alamos) but was present in 2 of 4 of EG samples. The immuno-dominant region (IDR) sequences derived from EG sera were unique in that none of the sequences were completely homologous to other HIV-1 group O variants. Further, the HIV-1 group O sequence variation could be correlated with differential serologic reactivity using IDR peptides. Compared to HIV-1, the sequence information on HIV-2 isolates is relatively limited, though the HIV-2 isolates also show genetic variation similar to HIV-1. To further establish a correlation between the genetic diversity and serologic detection of HIV-2, plasma samples from Western Africa were evaluated. Eight samples were selected based on weak serologic reactivity to env proteins. PCR amplification and sequence analysis of the gag, env V3 loop, and env IDR regions indicated that the samples could be classified as subtypes A (4 samples), B (3 samples) and D (1 sample). Across the subtypes, there was conservation in the IDR region of the sequence WGCAFRQVCHT. This region is absolutely conserved among the majority of currently known HIV-2 and related SIV viruses (1994 HIV database). One subtype B sample had a unique sequence immediately adjacent to the IDR, however, this did not change the serologic detection using a HIV-2 IDR specific monoclonal antibody.
authors.affiliation: Abbott Laboratories, North Chicago, IL-60064, USA.
authors.forename: J C
authors.initials: JC
authors.lastname: Hunt
authors.forename: C A
authors.initials: CA
authors.lastname: Brennan
authors.forename: A M
authors.initials: AM
authors.lastname: Golden
authors.forename: J
authors.initials: J
authors.lastname: Yamaguchi
authors.forename: J K
authors.initials: JK
authors.lastname: Lund
authors.forename: A S
authors.initials: AS
authors.lastname: Vallari
authors.forename: R K
authors.initials: RK
authors.lastname: Hickman
authors.forename: L
authors.initials: L
authors.lastname: Zekeng
authors.forename: L G
authors.initials: LG
authors.lastname: Gürtler
authors.forename: H
authors.initials: H
authors.lastname: Hampl
authors.forename: L
authors.initials: L
authors.lastname: Kaptué
authors.forename: S G
authors.initials: SG
authors.lastname: Devare
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000821:virology; D000354:Africa, Western; D000595:Amino Acid Sequence; D001782:Blood Donors; D002163:Cameroon; D016703:Equatorial Guinea; D005260:Female; D015686:Gene Products, env / Q000737:chemistry; D015752:Genes, env; D014644:Genetic Variation; D015497:HIV-1 / Q000145:classification / Q000235:genetics* / Q000302:isolation & purification*; D015498:HIV-2 / Q000145:classification / Q000235:genetics* / Q000302:isolation & purification*; D006801:Humans; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D012367:RNA, Viral / Q000302:isolation & purification; D012703:Serotyping
chemical_list: D015686:Gene Products, env; D012367:RNA, Viral